colorectal-cancer

Documents about colorectal-cancer

• Image 5_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.tif#353678Figshare
• Image 1_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.tif#353679Figshare
• Table 9_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.xlsx#353680Figshare
• Image 4_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.tif#353681Figshare
• Table 14_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.xlsx#353682Figshare
• Table 11_Cross-sectional gut microbiota and serum metabolite differences across clinically defined groups in colorectal cancer.xlsx#353683Figshare
• Impact of stromal maturity and proportion on prognosis and immune landscape in colorectal cancer.#9602PubMed
• Estradiol Reshapes Cell-Type-Dependent Basal Redox Set-Points in Colorectal Carcinoma Cells#482730IBISS
• Prognostic Factors and Oncological Outcomes in Laparoscopic Liver Resection for CRLM#828386ClinicalTrials.gov
• Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease#826766ClinicalTrials.gov
• A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens#426789ClinicalTrials.gov
• The Epidemiology of colorectal cancer in Guangzhou, China: A cross-sectional and age-period-cohort study#248065PLOS
• Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.#405169ClinicalTrials.gov
• Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors#140996ClinicalTrials.gov
• EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer#148578ClinicalTrials.gov
• Liquid BiOpsy, Lung and Colon Cancer in AndaluciA#195316ClinicalTrials.gov
• REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients#828474ClinicalTrials.gov
• A comprehensive European Colorectal Cancer Cohort dataset.#143215NCBI PubMed Central
• Multimodal radiomics for precision management of colorectal cancer.#157204NCBI PubMed Central
• Long-term lifestyle effects of prehabilitation in colorectal cancer.#244160NCBI PubMed Central
• Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer#685059HAL (France)
• AGARIC Case Control Study#828300ClinicalTrials.gov
• Escherichia coli producteurs de la toxine cytotoxique nécrosante de type 1 et la carcinogenèse colorectale : Implication de l'autophagie#308236HAL (France)
• Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.#398191ClinicalTrials.gov
• Determining and characterizing circulating nucleosomes in advanced cancer with electrochemical biosensors assisted by magnetic supports and proteomic technologies.#479588Repisalud
• Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)#828325ClinicalTrials.gov
• Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation#828989ClinicalTrials.gov
• Effectiveness of Care in Certified Cancer Centres in Germany#806143ClinicalTrials.gov
• Subsequent primary cancer incidence among cancer survivors in the United States, 1975–2019: An age–period–cohort analysis#141261PLOS
• Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients#810128ClinicalTrials.gov
• Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy#261520ClinicalTrials.gov
• Impacts of mutation accumulation and order on tumor initiation revealed by engineered murine colorectal cancer organoids#332410bioRxiv / medRxiv
• Mariposa FIT Focus Groups#342886UNC Dataverse Dataverse OAI Archive
• Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer#346921ClinicalTrials.gov
• Risk of secondary appendiceal tumours after colorectal cancer surgery: nationwide Swiss registry study#640265Apollo
• The Effect of Inulin Supplementation on Colorectal Surgery Outcomes#830206ClinicalTrials.gov
• Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial#811593ClinicalTrials.gov
• Impact of Obesity on Textbook Outcome Achievement in Minimally Invasive Colorectal Cancer Surgery#811608ClinicalTrials.gov
• Colorectal cancer screening in carceral settings: barriers and opportunities to improve early detection among incarcerated individuals#814054DigitalCommons@WayneState
• Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer#18621ClinicalTrials.gov
• Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy#828541ClinicalTrials.gov
• Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening Intervention#802943ClinicalTrials.gov
• Oxaliplatin-induced Portal Hypertension#184701ClinicalTrials.gov
• Navigation and clinician payment investments enhance colorectal cancer screening benefits.#327156NCBI PubMed Central
• 125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer#383579ClinicalTrials.gov
• Colorectal cancer screening awareness among rural populations in Northern China.#415551NCBI PubMed Central
• Essential Updates 2024-2026: Advances in Colorectal Cancer Surgery.#423158NCBI PubMed Central
• "Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"#471446ClinicalTrials.gov
• 4-week Serial FIT Analysis in Patients With CRC#471530ClinicalTrials.gov
• Macrophage PABPC4-SPP1 Axis Orchestrates Immunosuppression in Colorectal Cancer.#479344NCBI PubMed Central